Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Flu and RSV 2018–19 season and vaccine effectiveness against the need for hosp...
Journal Information
Vol. 155. Issue 3.
Pages 119-122 (August 2020)
Share
Share
Download PDF
More article options
ePub
Visits
0
Vol. 155. Issue 3.
Pages 119-122 (August 2020)
Brief report
Flu and RSV 2018–19 season and vaccine effectiveness against the need for hospital flu treatment in Guadalajara province, Spain
Temporada de gripe y VRS 2018-19 y efectividad vacunal frente a la necesidad de atención hospitalaria por gripe en la provincia de Guadalajara
Visits
...
Olga Redondo Gonzáleza,
Corresponding author
oredgon@gmail.es

Corresponding author.
, Filip Camil Olteanu Olteanub, Juan José Arechederra Calderónc, Clara María Bravo Villaseñord, Isabel Miras Aguilarb, Jorge Rodríguez Arbaizara
a Servicio de Medicina Preventiva, Hospital Universitario de Guadalajara, Guadalajara, Spain
b Servicio de Pediatría, Hospital Universitario de Guadalajara, Guadalajara, Spain
c Servicio de Geriatría, Hospital Universitario de Guadalajara, Guadalajara, Spain
d Academia Central de la Defensa, Madrid, Spain
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (2)
Table 1. Characteristics of the patients treated at the University Hospital of Guadalajara for flu or RSV during the 2018–2019 season.
Table 2. Effectiveness of flu vaccine in preventing cases in need of hospital care and death, by age group. Guadalajara, Spain. Season 2018–2019.a
Show moreShow less
Abstract
Introduction

The objective was to estimate the effectiveness of inactivated trivalent vaccine (VE) in preventing hospital flu care (HFC) in Guadalajara, Castile-La Mancha (CLM), Spain, 2018–19 season.

Material and methods

Retrospective cohort study (40/2018 to 13/2019 weeks). Sources: Microbiology programme; electronic medical history; population census (INE, 1/7/2018). Cases: Population requiring HFC (hospital emergencies and/or emergency observation unit and/or hospital admissions), confirmed by antigenic test and/or PCR. Preventive fractions [PFv(vaccinated) and PFp(population)] and necessary number of patients to be vaccinated (NNV) were calculated.

Results

228 HFT occurred [cumulative incidence rate (IR)=8.9/104; ≥65 years=65%; vaccination coverage=13% (≥65 years=58%; mortality=9%); maximum incidence in the 6th week (IR=1.7/104) (in CLM, in 4th)]. Highest peak of RSV occurred in the 3rd (in CLM, in the 52th). PFv (14–65 years) was 96% (PFp=58%) and in ≥65, 32% (PFp=21%). NNV=414. As in Spain, influenza virus A predominated, with A(H3N2) being 13% more prevalent (strain not included in the vaccine).

Conclusions

The season was delayed by sustained VRS circulation. The VE was lower than the national one. It is be essential to promote future campaigns to improve vaccination coverage.

Keywords:
Influenza virus
Respiratory syncytial virus
Effectiveness
Vaccination coverage
Hospital care
Resumen
Introducción

El objetivo fue estimar la efectividad de la vacuna (EV) trivalente inactivada para prevenir atenciones hospitalarias por gripe (AHG) en Guadalajara, Castilla-La Mancha (CLM), España, temporada 2018-2019.

Material y métodos

Estudio de cohortes retrospectivo; semanas 40/2018 a 13/2019. Fuentes: Programa Microbiología; historia clínica electrónica; censo poblacional (INE, 1/7/2018). Casos: AHG (urgencias y/u observación de urgencias o ingreso), confirmadas mediante prueba antigénica o PCR. Se calcularon: fracciones preventivas ([FPv(vacunados) y FPp(poblacional)]) y número necesario de pacientes a vacunar (NNV).

Resultados

Hubo 228 AHG (tasa incidencia [TI] acumulada=8,9/104; ≥65 años=65%; cobertura vacunal=13% [≥65 años=58%]; mortalidad=9%); con máxima incidencia en la semana 6.ª (TI=1,7/104) (en CLM, en la 4.ª). El mayor pico de VRS ocurrió en la 3.ª semana (en CLM, en la 52). La FPv entre 14-65 años fue del 96% (FPp=58%) y en ≥65, del 32% (FPp=21%). NNV=414. Como en España, predominó el virus A, siendo A(H3N2) un 13% más prevalente (cepa no concordante con la vacunal).

Conclusiones

La temporada se retrasó por una sostenida circulación del VRS. La EV resultó inferior a la nacional. Sería imprescindible impulsar próximas campañas para mejorar la cobertura.

Palabras clave:
Gripe
Virus respiratorio sincitial
Efectividad
Cobertura de vacunación
Atención hospitalaria

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos